Rufibachstrasse 11, 6318 Walchwil, Switzerland.
Rufibachstrasse 11, 6318 Walchwil, Switzerland.
Performing perioperative quality assessment using Medistim technology greatly increases the patient’s probability of a positive outcome and lessens the chance of additional and unnecessary surgical reinterventions.
The MiraQ™ Vascular system provides objective, quantifiable feedback on how well a graft is functioning during an operation. Surgeons can leave the operating room with the assurance that the construct is functioning well. All surgical findings can be documented through the flow tracings and images provided by the Medistim system.
The MiraQ™ Vascular system offers the unique combination of high frequency ultrasound imaging guidance and flow measurement (TTFM). Documented to reduce risk of death and stroke and improve cost effectiveness.
With graft patency being the predominant predictor of long-term graft survival, surgeons can improve patient quality of life and reduce reinterventions, using the MiraQ™ Vascular system.
Flow quantification and intraoperative guidance are valuable tools for performing AV Access surgery. This improves the probability of a long lasting well-functioning shunt, reduce the risk of cardiac failure and hand ischemia.
Performing perioperative quality assessment using Medistim technology can greatly increase the patients’ probability of a positive outcome and lessen the chance of additional and unnecessary surgical reinterventions.
The MiraQ™ Vascular system provides objective, quantifiable feedback on how well a graft is functioning during an operation. Surgeons can leave the operating room with the assurance that the construct is functioning well. All surgical findings can be documented through the flow tracings and images provided by the Medistim system.
Medistim Vascular TTFM probes are designed with a locking slide to facilitate gentle handling of fragile vessels. Available with and without handle. Size range from 1.5 – 16mm. Steam, Plasma, STERRAD autoclavable.
